Cargando…
The safety of combined triple drug therapy with ivermectin, diethylcarbamazine and albendazole in the neglected tropical diseases co-endemic setting of Fiji: A cluster randomised trial
Lymphatic filariasis has remained endemic in Fiji despite repeated mass drug administration using the well-established and safe combination of diethylcarbamazine and albendazole (DA) since 2002. In certain settings the addition of ivermectin to this combination (IDA) remains a safe strategy and is m...
Autores principales: | Hardy, Myra, Samuela, Josaia, Kama, Mike, Tuicakau, Meciusela, Romani, Lucia, Whitfeld, Margot J., King, Christopher L., Weil, Gary J., Grobler, Anneke C., Robinson, Leanne J., Kaldor, John M., Steer, Andrew C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7098623/ https://www.ncbi.nlm.nih.gov/pubmed/32176703 http://dx.doi.org/10.1371/journal.pntd.0008106 |
Ejemplares similares
-
Community control strategies for scabies: A cluster randomised noninferiority trial
por: Hardy, Myra, et al.
Publicado: (2021) -
Costs of mass drug administration for scabies in Fiji
por: Mow, Maria, et al.
Publicado: (2022) -
Country Reports on Practical Aspects of Conducting Large-Scale Community Studies of the Tolerability of Mass Drug Administration with Ivermectin/Diethylcarbamazine/Albendazole for Lymphatic Filariasis
por: Jambulingam, Purushothaman, et al.
Publicado: (2022) -
Hospital admissions for skin and soft tissue infections in a population with endemic scabies: A prospective study in Fiji, 2018–2019
por: Thean, Li Jun, et al.
Publicado: (2020) -
An open label, randomized clinical trial to compare the tolerability and efficacy of ivermectin plus diethylcarbamazine and albendazole vs. diethylcarbamazine plus albendazole for treatment of brugian filariasis in Indonesia
por: Supali, Taniawati, et al.
Publicado: (2021)